宏達新材(002211.SZ):上海鴻孜原持有的3444萬股已過户至杭州科立名下
格隆匯6月30日丨宏達新材(002211.SZ)公佈,2021年6月30日,中國證券登記結算有限責任公司出具了《證券過户登記確認書》,上海鴻孜原持有的公司股份3444萬股(佔公司總股本的7.96%)已過户登記至杭州科立名下。
截至目前,杭州科立持有公司3444萬無限售流通股股份,佔公司總股本的7.96%,為公司第三大股東。上海鴻孜持有公司股份8766萬股,佔公司總股本的20.27%,為公司控股股東,公司實際控制人為楊鑫。
上海鴻孜在收到杭州科立支付的首期股份轉讓款後即負責辦理剩餘8766萬股公司股份解凍手續,並在解凍完成後將上述8766萬股公司股份辦理過户至杭州科立名下。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.